HCFA Relaxes Grip On MCAC, Allowing Informal Comment On Coverage
This article was originally published in The Gray Sheet
Executive Summary
The Health Care Financing Administration is giving its Medicare Coverage Advisory Committee a wider berth in discussing whether or not a device warrants Medicare coverage during reviews by the various panels.
You may also be interested in...
MCAC Panel Takes "Clinical Common Sense" Approach To Coverage Review
HCFA's Medicare Coverage Advisory Committee reached a favorable decision for ambulatory blood pressure monitors (ABPMs) after adopting what it termed a "practical" approach for a technology that is difficult to study in a randomized setting.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.